Ery-Tab Oral Tablet, Gastro-Resistant 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ery-Tab: Oral tablet, gastro-resistant (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14732.JPG
Ery-Tab 250mg DR Tab
Arbor Pharmaceuticals, LLC
Pill Identification: LOGO  |  EC

What is this Medicine?

ERYTHROMYCIN (er ith roe MYE sin) is a macrolide antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Ery-Tab: Oral tablet, gastro-resistant(250mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ery-Tab 250mg Delayed-Release Tablet

NDC: 243380122
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Pertussis (whooping Cough), Urethritis, Impetigo, Upper Respiratory Tract Infections, Non-gonococcal Urethritis (NGU), Pharyngitis, Pertussis Prophylaxis, Chlamydia Infection, Rheumatic Fever Prophylaxis, Pelvic Inflammatory Disease (PID), Bronchitis, Bowel Preparation, Cervicitis, Tonsillitis, Proctitis, Legionnaire's Disease, Diphtheria, Listeriosis, Bacterial Colonization Eradication, Skin And Skin Structure Infections, Amebiasis, Erythrasma, Lower Respiratory Tract Infections

Sometimes used for but not FDA approved for the following conditions:
Bartonellosis, Pneumococcal Prophylaxis, Cholera, Sickle Cell Disease, Chancroid, Campylobacteriosis, Diabetic Gastroparesis, Granuloma Inguinale, Diphtheria Prophylaxis, Gonorrhea, Acne Vulgaris, Lyme Disease, Tetanus, Gastroparesis, Burn Wound Infection, Feeding Intolerance, Lymphogranuloma Venereum

Storage Information
Store below 86 degrees F
Ery-Tab 250mg Delayed-Release Tablet
Drug Image file DrugItem_14732.JPG
Arbor Pharmaceuticals, LLC
Pill Identification: LOGO  |  EC
Shape: oval
Color: white

Reported Side Effects for Ery-Tab 250mg Delayed-Release Tablet

Painful Swallowing Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Torsade De Pointes Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Throat Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ery-Tab 250mg Delayed-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Ery-Tab 250mg Delayed-Release Tablet(Erythromycin)
Grapefruit juice and Erythromycin(Erythromycin)
It is best not to change your usual intake of grapefruit juice while taking Erythromycin. Grapefruit juice can increase the amount of erythromycin absorbed by the body, which might increase the incidence of common, but troublesome side effects like nausea, loss of appetite, and abdominal pain.
Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Ery-Tab 250mg Delayed-Release Tablet(Erythromycin)
Caffeine-containing Foods/Beverages and Erythromycin(Erythromycin)
Although an interaction is possible, these drugs are often used together. Side effects from Caffeine may get worse if you take Erythromycin. Too much Caffeine can cause effects like nausea, nervousness, or sleeplessness. You may need to limit your Caffeine intake. Common foods and beverages containing caffeine include coffee, teas, colas and chocolate. Many non-prescription drugs and diet aids may also contain caffeine.
Moderate Lifestyle Interaction
Marijuana and Ery-Tab 250mg Delayed-Release Tablet(Erythromycin)
Marijuana and Erythromycin(Erythromycin)
Erythromycin can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Erythromycin. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ery-Tab

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5